| I-85 Maja Skataric Dabrafenib and Trametinib dose optimization in 6-17 year old tumor agnostic patients based on established efficacy surrogate targets in adults Wednesday 10:00-11:30 |
| I-85 Maja Skataric Dabrafenib and Trametinib dose optimization in 6-17 year old tumor agnostic patients based on established efficacy surrogate targets in adults Wednesday 10:00-11:30 |